Epigenomics
Pre-clinicalEpigenomcs AG acts as a holding company and is dedicated to managing its own assets, acquiring, holding and disposing of investments in companies in Germany and abroad, particularly in the field of minimally invasive blood tests for cancer detection, as well as investing in other assets. Latest News
Founded
1998
Focus
Diagnostics
About
Epigenomcs AG acts as a holding company and is dedicated to managing its own assets, acquiring, holding and disposing of investments in companies in Germany and abroad, particularly in the field of minimally invasive blood tests for cancer detection, as well as investing in other assets. Latest News
Funding History
2Total raised: $20M
PIPE$5MUndisclosedApr 15, 2012
IPO$15MUndisclosedJun 15, 2005
Company Info
TypePrivate
Founded1998
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile